v3.26.3
Certain Balance Sheet Components (Tables)
6 Months Ended
Sep. 30, 2026
Balance Sheet Related Disclosures [Abstract]
Schedule of Accrued Expenses
Accrued expenses at September 30, 2026 and March 31, 2026 consisted of the following (in thousands):
September 30, 2026
March 31, 2026
Research and development expenses
$
105,962
$
92,749
Compensation-related expenses
55,650
87,325
Other expenses
26,258
25,749
Total accrued expenses
$
187,870
$
205,823
X
- References
No definition available.
+ Details
Name:
us-gaap_BalanceSheetRelatedDisclosuresAbstract
Namespace Prefix:
us-gaap_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Tabular disclosure of the components of accrued liabilities.
+ References
No definition available.
+ Details
Name:
us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix:
us-gaap_
Data Type:
dtr-types:textBlockItemType
Balance Type:
na
Period Type:
duration